Table 4 Multivariate analysis
From: Circulating tumor cells in newly diagnosed inflammatory breast cancer
Variable | PFS | OS | ||
|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
ER/PR status | 0.630 | 0.051 | 0.468 | 0.004 |
Positive for either versus negative for both | (0.400 - 1.002) | (0.279 - 0.785) | ||
HER2 status | 0.309 | <0.001 | 0.268 | <0.001 |
Overexpressed versus negative | (0.173 - 0.554) | (0.138 - 0.521) | ||
Sites of metastases | 1.536 | 0.143 | 2.319 | 0.002 |
Visceral versus nonvisceral | (0.865 - 2.729) | (1.364 - 3.942) | ||
Stage | 2.939 | <0.001 | 1.681 | 0.131 |
mIBC versus stage III | (1.818 – 4.750) | (0.857 – 3.298) | ||
Baseline CTCs count | 1.621 | 0.044 | 1.995 | 0.008 |
≥5 versus <5 | (1.014 - 2.591) | (1.202 - 3.309) | ||